Galina Gritsina

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 8

Top Topics

Transforming Growth Factor

Prostate Cancer

Staphylococcus Aureus

Top Venues

Nature genetics

This page only lists publications with an associated author ORCID identifier.

Publications

Galina Gritsina, Jindan Yu
CXCR7 as a novel therapeutic target for advanced prostate cancer. Oncogene (2023)
Galina Gritsina, Jindan Yu
CXCR7 as a novel therapeutic target for advanced prostate cancer. Oncogene 42 (11) (2023)
Galina Gritsina, Jindan Yu
CXCR7 as a novel therapeutic target for advanced prostate cancer. Oncogene 42 (11) (2023)
Galina Gritsina, Jindan Yu
CXCR7 as a novel therapeutic target for advanced prostate cancer. Oncogene 42 (11) (2023)
Galina Gritsina, Jindan Yu
CXCR7 as a novel therapeutic target for advanced prostate cancer. Oncogene 42 (11) (2023)
Galina Gritsina, Jindan Yu
CXCR7 as a novel therapeutic target for advanced prostate cancer. Oncogene (2023)
Xiaohai Wang, Lourdes T Brea, Xiaodong Lu, Galina Gritsina, Su H Park, Wanqing Xie, Jonathan C Zhao, Jindan Yu
FOXA1 inhibits hypoxia programs through transcriptional repression of HIF1A. Oncogene 41 (37) (2022)
Xiaodong Lu, Ka-Wing Fong, Galina Gritsina, Fang Wang, Sylvan C Baca, Lourdes T Brea, Jacob E Berchuck, Sándor Spisák, Jenny Ross, Colm Morrissey, Eva Corey, Navdeep S Chandel, William J Catalona, Ximing Yang, Matthew L Freedman, Jonathan C Zhao, Jindan Yu
HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer. Nature genetics 54 (5) (2022)